Jan 27, 2021 | Press Releases
– Spain marks INVO’s initial entry into the European market- Europe represents approximately 30% of the multi-billion dollar global fertility marketplace- The first three clinics in Spain have placed initial orders for INVOcell – an effective and...
Jan 27, 2021 | Press Releases
– Spain marks INVO’s initial entry into the European market- Europe represents approximately 30% of the multi-billion dollar global fertility marketplace- The first three clinics in Spain have placed initial orders for INVOcell – an effective and...
Jan 15, 2021 | Press Releases
– Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan- Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million...
Jan 15, 2021 | Press Releases
– Signs distribution agreement with Galaxy Pharma Ltd., the clear market leader of infertility products and services in Pakistan- Seeks to expand access to infertility care in the fifth most populous country in the world, Pakistan, with approximately 212 million...
Jan 7, 2021 | Press Releases
Key Developments and Future Initiatives Position INVOcell® Within the Severely Underserved Fertility MarketSARASOTA, Fla., Jan. 7, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO) (“Company”) (‘INVO”), a medical device company...
